We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.51B
AUM Growth
+$285M
Cap. Flow
+$251M
Cap. Flow %
7.15%
Top 10 Hldgs %
19.24%
Holding
1,493
New
125
Increased
759
Reduced
470
Closed
79
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI.WS
1376
DELISTED
Kinder Morgan Inc
KMI.WS
$44K ﹤0.01%
10,825
-11,072
-51% -$43.1K
PLM
1377
DELISTED
PolyMet Mining Corp.
PLM
$44K ﹤0.01%
3,410
+625
+22% +$7.07K
ACI
1378
DELISTED
ARCH COAL, INC.
ACI
$43K ﹤0.01%
4,313
+111
+3% +$1.29K
III icon
1379
Information Services Group
III
$250M
$41K ﹤0.01%
10,247
AMRN
1380
Amarin Corp
AMRN
$297M
$35K ﹤0.01%
+750
New +$22.9K
OCLR
1381
DELISTED
Oclaro Inc.
OCLR
$35K ﹤0.01%
17,500
+1,500
+9% +$2.5K
ZN
1382
DELISTED
Zion Oil & Gas, Inc.
ZN
$34K ﹤0.01%
19,477
-250
-1% -$421
AXAS
1383
DELISTED
Abraxas Petroleum Corp
AXAS
$33K ﹤0.01%
+510
New +$31.6K
DRYS
1384
DELISTED
DryShips Inc. Common Stock
DRYS
0
SCON
1385
DELISTED
Superconductor Technologies Inc.
SCON
$21K ﹤0.01%
10
RXII
1386
DELISTED
GALENA BIOPHARMA INC COM
RXII
$21K ﹤0.01%
15,094
+1,275
+9% +$1.77K
ANR
1387
DELISTED
Alpha Natural Resources Inc
ANR
$20K ﹤0.01%
19,858
+1,108
+6% +$1.26K
GAZ
1388
DELISTED
iPath Bloomberg Natural Gas Subindex Total Return ETN due October 22, 2037
GAZ
$17K ﹤0.01%
+14,322
New +$22.5K
RBY
1389
DELISTED
RUBICON MENERALS CORP (F)
RBY
$17K ﹤0.01%
18,039
-900
-5% -$973
TRX icon
1390
TRX Gold Corp
TRX
$344M
$16K ﹤0.01%
47,050
-2,000
-4% -$1.04K
CGRN
1391
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$16K ﹤0.01%
124
+20
+19% +$2.74K
MGN
1392
DELISTED
MINES MGMT INC
MGN
$15K ﹤0.01%
34,200
FCEL icon
1393
FuelCell Energy
FCEL
$1.58B
$14K ﹤0.01%
+3
New +$16.6K
ETRM
1394
DELISTED
EnteroMedics Inc.
ETRM
$14K ﹤0.01%
15
MUX icon
1395
McEwen Inc
MUX
$1.16B
$12K ﹤0.01%
+1,215
New +$13.6K
CSCI
1396
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$11K ﹤0.01%
2
+1
+100% +$5.73K
GSS
1397
DELISTED
Golden Star Resources Ltd.
GSS
$10K ﹤0.01%
8,322
-500
-6% -$734
WLT
1398
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$7K ﹤0.01%
10,606
-100
-0.9% -$93
LODE icon
1399
Comstock
LODE
$271M
$6K ﹤0.01%
42
-2
-5% -$413
ERN
1400
DELISTED
Erin Energy Corp
ERN
$6K ﹤0.01%
2,029

Similar funds

Cambridge Investment Research Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Cambridge Investment Research Advisors held 1,493 positions worth $3.51B, up 8.8% from $3.23B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $251M of net new capital in Q1 2015, opening 125 new positions and adding to 759 existing holdings. Its largest new stake was ProShares UltraShort S&P500: 4,130 shares worth $8.81M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was State Street SPDR Bloomberg International Treasury Bond ETF, an estimated $21.1M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2015 buy was ProShares UltraShort S&P500: 4,130 shares worth $8.81M.
  • Cambridge Investment Research Advisors added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2015, an estimated $15.8M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2015 reduction was State Street SPDR Bloomberg International Treasury Bond ETF, cutting an estimated $21.1M.
  • Cambridge Investment Research Advisors fully exited Medtronic in Q1 2015, selling an estimated $4.31M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $3.51B portfolio in Q1 2015.
  • Cambridge Investment Research Advisors opened 125 new positions and closed 79 in Q1 2015.
  • Cambridge Investment Research Advisors's portfolio value rose 8.8% quarter-over-quarter to $3.51B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2015, filed 4 May 2015.